PPAR
The peroxisome proliferator-activated receptors (PPARs), belonging to the nuclear receptor superfamily, are a group of nuclear receptor proteins that are composed of three isoforms, including PPARγ, PPARα and PPARδ, encoded by separate genes. PPARs have a modular structure characterized by the presence of two highly conserved domains, including the DNA binding domain (DBD) of two zinc fingers and the ligand binding domain (LBD) of 13 α-helices and a small 4-stranded β-sheet. PPARs are ligand-regulated transcription factors controlling gene expression by binding to specific response elements (PPREs) within promoters, where PPARs bind as heterodimers with a retinoid X receptor and interact with cofactors upon binding leading to the increasing of rate of transcription initiation.
- C5671 RB394Summary: dual modulator of soluble epoxide hydrolase (sEH) and PPARγ
- B5581 SR 1664Summary: inhibits Cdk5-mediated PPARγ phosphorylation, antidiabetic agent
- A8957 AUDASummary: Potent epoxide hydrolase inhibitor/PPARα activator
- B2117 PioglitazoneSummary: PPAR agonist
- B1943 Fenofibrate1 CitationSummary: PPARα agonist
- B1947 GemfibrozilSummary: PPARα activator
- B6128 Fenofibric acidSummary: ppar inhibitor, lipid-lowering agent
- C3407 GQ-16Summary: partial agonist for PPARγ
- C3544 BMS 687453Summary: PPARα agonist
- C3986 MuraglitazarSummary: dual agonist of PPARα and PPARγ